Tag: Treatments
Business & Industry
Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal
Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational...
Business & Industry
Weight-Loss Pills Mark a Turning Point for Pharma Industry
The global pharmaceutical industry is entering a pivotal phase in obesity therapeutics as companies accelerate the transition from injectable GLP-1 drugs to oral weight-loss...
Drug Research
Future Trends in Pharmaceutical Drug Delivery Platforms
Forward-looking perspective on the convergence of digital technology, bioengineering, and material science in creating the next generation of therapeutic delivery systems.
Drug Research
Drug Delivery Innovations Supporting Personalized Medicine
Investigation into the technological advancements that enable individualized therapeutic regimens, focusing on precision dosing, genetic tailoring, and smart delivery systems.
Clinical Trials
Nanotechnology Applications in Drug Delivery Development
Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.
Business & Industry
Daiichi Eyes Commercialization of its Leukemia Med Vanflyta
Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug...
Business & Industry
Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity
Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read